Matches in SemOpenAlex for { <https://semopenalex.org/work/W3165742733> ?p ?o ?g. }
- W3165742733 endingPage "2833" @default.
- W3165742733 startingPage "2824" @default.
- W3165742733 abstract "Maintenance therapy containing methotrexate and 6-mercapto - purine is essential to cure acute lymphoblastic leukemia (ALL). Cytotoxicity is elicited by incorporation of thioguanine nucleotides into DNA (DNA-TG), and higher leukocyte DNA-TG is associated with increased relapse-free survival. As 6-thioguanine provides 6- fold higher cytosolic levels of thioguanine nucleotides than does 6- mercapto purine, we added low-dose 6-thioguanine to methotrexate/6- mercapto purine maintenance therapy to explore if this combination results in significantly higher DNA-TG. The target population of the “Thiopurine Enhanced ALL Maintenance therapy” (TEAM) study was 30 patients with non-high-risk ALL, aged 1-45 years on methotrexate/6-mercaptopurine maintenance therapy receiving no other systemic chemotherapy. Incremental doses of 6-thioguanine were added to methotrexate/6-mercaptopurine maintenance therapy (starting 6-thioguanine dose: 2.5 mg/m2/day, maximum: 12.5 mg/m2/day). The primary endpoint was DNA-TG increments. Thirty-four patients were included, and 30 patients completed maintenance therapy according to the TEAM strategy. Of these 30 patients, 26 (87%) tolerated 10.0-12.5 mg/m2/day as the maximum 6-thioguanine dose. TEAM resulted in significantly higher DNA-TG levels compared to those in both TEAM patients before their inclusion in TEAM (on average 251 fmol/mg DNA higher [95% confidence interval: 160-341; P<0.0001]), and with historical patients receiving standard methotrexate/6-mercapto - purine maintenance therapy (on average 272 fmol/mg DNA higher [95% confidence interval: 147-398; P<0.0001]). TEAM did not increase myelotoxicity or hepatotoxicity. In conclusion, TEAM is an innovative and feasible approach to improve maintenance therapy and results in higher DNA-TG levels without inducing additional toxicity. It may therefore be an effective strategy to reduce the risk of ALL relapse through increased DNA-TG. This will be tested in a randomized ALLTogether-1 substudy." @default.
- W3165742733 created "2021-06-07" @default.
- W3165742733 creator A5001744506 @default.
- W3165742733 creator A5007917870 @default.
- W3165742733 creator A5017466426 @default.
- W3165742733 creator A5022304220 @default.
- W3165742733 creator A5027907656 @default.
- W3165742733 creator A5031395664 @default.
- W3165742733 creator A5037827311 @default.
- W3165742733 creator A5047221635 @default.
- W3165742733 creator A5058721183 @default.
- W3165742733 creator A5061101380 @default.
- W3165742733 creator A5063115909 @default.
- W3165742733 creator A5064924756 @default.
- W3165742733 creator A5065164974 @default.
- W3165742733 creator A5071720008 @default.
- W3165742733 creator A5072921521 @default.
- W3165742733 creator A5074845542 @default.
- W3165742733 creator A5078744414 @default.
- W3165742733 creator A5086774156 @default.
- W3165742733 date "2021-05-27" @default.
- W3165742733 modified "2023-10-16" @default.
- W3165742733 title "Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemia" @default.
- W3165742733 cites W1606371069 @default.
- W3165742733 cites W1801876107 @default.
- W3165742733 cites W1970459379 @default.
- W3165742733 cites W1972756160 @default.
- W3165742733 cites W1978042853 @default.
- W3165742733 cites W1983279908 @default.
- W3165742733 cites W1993379102 @default.
- W3165742733 cites W2018350078 @default.
- W3165742733 cites W2024884240 @default.
- W3165742733 cites W2038604255 @default.
- W3165742733 cites W2044141667 @default.
- W3165742733 cites W2058471639 @default.
- W3165742733 cites W2061069132 @default.
- W3165742733 cites W2076057372 @default.
- W3165742733 cites W2079689830 @default.
- W3165742733 cites W2089190709 @default.
- W3165742733 cites W2094546718 @default.
- W3165742733 cites W2105410494 @default.
- W3165742733 cites W2120420315 @default.
- W3165742733 cites W2149350612 @default.
- W3165742733 cites W2159913536 @default.
- W3165742733 cites W2161927278 @default.
- W3165742733 cites W2168127783 @default.
- W3165742733 cites W2170692626 @default.
- W3165742733 cites W2172173460 @default.
- W3165742733 cites W2307154186 @default.
- W3165742733 cites W2410554704 @default.
- W3165742733 cites W2413038045 @default.
- W3165742733 cites W2480796907 @default.
- W3165742733 cites W2513725245 @default.
- W3165742733 cites W2593461816 @default.
- W3165742733 cites W2745522463 @default.
- W3165742733 cites W2789860721 @default.
- W3165742733 cites W2950699055 @default.
- W3165742733 cites W3084591116 @default.
- W3165742733 doi "https://doi.org/10.3324/haematol.2020.278166" @default.
- W3165742733 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8561300" @default.
- W3165742733 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34047177" @default.
- W3165742733 hasPublicationYear "2021" @default.
- W3165742733 type Work @default.
- W3165742733 sameAs 3165742733 @default.
- W3165742733 citedByCount "14" @default.
- W3165742733 countsByYear W31657427332021 @default.
- W3165742733 countsByYear W31657427332022 @default.
- W3165742733 countsByYear W31657427332023 @default.
- W3165742733 crossrefType "journal-article" @default.
- W3165742733 hasAuthorship W3165742733A5001744506 @default.
- W3165742733 hasAuthorship W3165742733A5007917870 @default.
- W3165742733 hasAuthorship W3165742733A5017466426 @default.
- W3165742733 hasAuthorship W3165742733A5022304220 @default.
- W3165742733 hasAuthorship W3165742733A5027907656 @default.
- W3165742733 hasAuthorship W3165742733A5031395664 @default.
- W3165742733 hasAuthorship W3165742733A5037827311 @default.
- W3165742733 hasAuthorship W3165742733A5047221635 @default.
- W3165742733 hasAuthorship W3165742733A5058721183 @default.
- W3165742733 hasAuthorship W3165742733A5061101380 @default.
- W3165742733 hasAuthorship W3165742733A5063115909 @default.
- W3165742733 hasAuthorship W3165742733A5064924756 @default.
- W3165742733 hasAuthorship W3165742733A5065164974 @default.
- W3165742733 hasAuthorship W3165742733A5071720008 @default.
- W3165742733 hasAuthorship W3165742733A5072921521 @default.
- W3165742733 hasAuthorship W3165742733A5074845542 @default.
- W3165742733 hasAuthorship W3165742733A5078744414 @default.
- W3165742733 hasAuthorship W3165742733A5086774156 @default.
- W3165742733 hasBestOaLocation W31657427331 @default.
- W3165742733 hasConcept C126322002 @default.
- W3165742733 hasConcept C181199279 @default.
- W3165742733 hasConcept C2776476023 @default.
- W3165742733 hasConcept C2776694085 @default.
- W3165742733 hasConcept C2776760755 @default.
- W3165742733 hasConcept C2777173762 @default.
- W3165742733 hasConcept C2778283404 @default.
- W3165742733 hasConcept C2778461978 @default.
- W3165742733 hasConcept C2779134260 @default.
- W3165742733 hasConcept C2781059491 @default.